Kazia Therapeutics
Mr Iain Ross is an experienced multinational pharmaceutical and biotechnology executive and is currently Chairman of Redx Pharma plc (LON:REDX), Silence Therapeutics plc (LON:SLN) and Biomer Technology Limited.
During his career, Mr Ross has held senior positions at multinational companies, Sandoz AG, Hoffman La Roche, and Celltech Group PLC and been a Chairman, CEO and Director of several biotech companies. He is a qualified Chartered Director and former Vice Chairman of the Council of Royal Holloway, London University.
Mr Ross was appointed as a director of the Company in July 2015 and is considered to be an independent director.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Kazia Therapeutics
3 followers
Kazia Therapeutics is an oncology-focused biotechnology company, developing innovative anti-cancer drugs. Headquartered in Sydney, Australia, Kazia Therapeutics collaborates with leading scientists, clinicians, and investors around the world.